Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Centocor Ortho Biotech Statement On The FDA ODAC Opinion Regarding DOXIL(R) For Treatment Of Advanced Breast Cancer
Based on the data presented, the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended that the combination of DOXIL(R) (doxorubicin HCI liposome injection) and docetaxel did not provide a sufficient benefit-risk profile for first-line treatment of locally advanced or metastatic breast cancer.

Ethics Review Of Research In The Context Of Humanitarian Relief Work
Two articles published this week in the open-access journal PLoS Medicine
News of the day
Multiple Myeloma Research Consortium (MMRC) Activates Clinical Trials 30-40 Percent Faster Than Industry Standard
The Multiple Myeloma Research Consortium (MMRC), an innovative research model comprised of a network of 15 academic Member Institutions across North America and leadership in Norwalk, Connecticut, announced preliminary data from an analysis showing that clinical trials opened through its clinical trials network were activated 30 to 40 percent faster than comparable clinical trials in oncology. Based on the implementation of specific business solutions, particularly scientific leadership, standardized clinical contracts and on-site project management res, the MMRC has been able to decrease by an average of 100 days the time from the development and finalization of the trial"s protocol to actual patient enrollment.
Oncology

Looking For Excellence - NHS Alliance Launches Acorn Awards 2009

Entries are invited for the 2009 NHS Alliance Acorn Awards. This year, the awards, which recognise excellence in primary care, have nine categories. Since last year, the NHS Alliance introduced a new category, Pharmaceutical Services Commissioning, which has been designed to showcase Primary Care Trusts which are excelling at world class commissioning of pharmaceutical services. This year"s categories are: - Service Redesign/Improvement - Clinical Engagement - Public/Patient Involvement - Public Health - Integrated and Complementary Healthcare - Clinical Governance - Responsiveness in General Practice - Practice Based Commissioning - Pharmaceutical Services Commissioning NHS Alliance Chairman Dr Michael Dixon said: "We want to celebrate the success of those going the extra mile to bring excellence to primary care services. There are people up and down the country achieving really remarkable things. We want them to share their example of best practice and commemorate their achievements." Notes 1. The NHS Alliance is a collaboration of clinicians, managers and board members who put patients first. It is the independent body that represents NHS primary care. Values based, it is the only organisation that brings together PCTs with GP practices, clinicians with managers and Board members, and NHS primary care with its patients. NHS Alliance


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009